Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released May 7, 2013, after the close
10-Q filed May 7, 2013, 37 days after period end · 0001193125-13-204467
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|
| Revenue | $417.00K | $450.00K | $435.00K |
| Net Income | -$6.12M | -$6.22M | -$5.83M |
| EPS Diluted | -$0.08 | -$0.12 | -$0.12 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
